isotretinoin and Facial-Neoplasms

isotretinoin has been researched along with Facial-Neoplasms* in 6 studies

Reviews

2 review(s) available for isotretinoin and Facial-Neoplasms

ArticleYear
Trichilemmal cyst nevus with a sebaceous nevus component.
    Dermatology (Basel, Switzerland), 2010, Volume: 221, Issue:4

    A 23-year-old man with a typical trichilemmal cyst nevus is reported. This recently described disorder is sufficiently characteristic to differentiate it from sebaceous nevus, nevus comedonicus, porokeratotic eccrine nevus, nevus corniculatus, follicular basaloid hamartoma, Munro's nevus and Gardner's syndrome.

    Topics: Dermatologic Agents; Epidermal Cyst; Facial Neoplasms; Humans; Isotretinoin; Male; Nevus; Skin Neoplasms; Sweat Gland Neoplasms; Treatment Outcome; Young Adult

2010
[Muir-Torre syndrome. Diagnostic criteria and review of the literature].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1995, Volume: 46, Issue:2

    We report on a 63-year-old female patient with Muir-Torre syndrome (MTS). In the course of this disease two carcinomas of the colon, a kerato-acanthoma and multiple sebaceous gland tumours, including four sebaceous carcinomas, appeared. This case is thought to be a hereditary form as one of daughters was also found to have a sebaceous epithelioma. MTS is a mostly autosomal-dominant disease with the association of sebaceous gland tumours and internal carcinomas. As the malignant tumours only show slight aggressiveness the prognosis is quite favourable. Oral isotretinoin therapy was successfully used for the inhibition of sebaceous gland proliferation. A narrower definition is presented and an updated survey of the published cases is given. Furthermore, the histopathologic peculiarities of sebaceous gland tumours, especially of sebaceous gland carcinomas, are discussed and compared to sebaceous gland tumours not connected with MTS. A total number of 100 of the 135 published cases of MTS were included and analysed regarding sebaceous gland tumours and other skin tumours. The data on internal carcinomas were taken from the work of Cohen et al. (1991) and 11 current cases were added.

    Topics: Adenocarcinoma; Adenoma, Sweat Gland; Adenomatous Polyposis Coli; Administration, Oral; Carcinoma; Carcinoma, Squamous Cell; Chromosome Aberrations; Chromosome Disorders; Diagnosis, Differential; Facial Neoplasms; Female; Genes, Dominant; Humans; Isotretinoin; Keratoacanthoma; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Neoplastic Syndromes, Hereditary; Sebaceous Gland Neoplasms; Sweat Glands; Syndrome

1995

Other Studies

4 other study(ies) available for isotretinoin and Facial-Neoplasms

ArticleYear
[Isotretinoin: more adverse reactions].
    Annales de dermatologie et de venereologie, 2007, Volume: 134, Issue:10 Pt 1

    Topics: Adolescent; Dermatologic Agents; Facial Neoplasms; Hemangioma; Humans; Isotretinoin; Male

2007
[Complete remission of cutaneous squamous cell carcinoma treated with interferon alpha and 2a-isotretinoin after failure of usual treatments].
    Annales de dermatologie et de venereologie, 1993, Volume: 120, Issue:11

    Topics: Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Facial Neoplasms; Humans; Interferon-alpha; Isotretinoin; Male; Remission Induction; Skin Neoplasms; Treatment Outcome

1993
Cowden's disease (multiple hamartoma and neoplasia syndrome) treated with isotretinoin.
    Journal of the American Academy of Dermatology, 1986, Volume: 14, Issue:1

    Topics: Facial Neoplasms; Female; Hamartoma; Humans; Isotretinoin; Middle Aged; Neoplasms, Multiple Primary; Tretinoin

1986
Osteoma cutis: a case of probable exacerbation following treatment of severe acne with isotretinoin.
    Dermatologica, 1985, Volume: 170, Issue:4

    A florid case of osteoma cutis was observed following isotretinoin treatment of severe cystic acne in which a few scattered osteomata of the skin were observed prior to the treatment with isotretinoin.

    Topics: Acne Vulgaris; Adult; Facial Neoplasms; Female; Humans; Isomerism; Isotretinoin; Osteoma; Skin Neoplasms; Time Factors; Tretinoin

1985